3 results match your criteria: "Taiyuan Hospital of Peking University First Hospital[Affiliation]"
J Cancer
September 2024
School of Public Health, Shanxi Medical University, Taiyuan 030001, China.
This study aims to evaluate the prognostic significance of preoperative serum cystatin C (Cys-C) in patients with renal cell carcinoma (RCC). We analyzed clinicopathological data and follow-up information of 624 RCC patients who underwent partial or radical nephrectomy at our institution. The optimal cutoff value of Cys-C was determined using X-tile software.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
August 2024
Department of Orthopaedics, Taiyuan Hospital of Peking University First Hospital (Taiyuan Central Hospital), No. 1, East Sandao Lane, Jiefang Road, Taiyuan, 030000, Shanxi Province, China.
Chronic osteomyelitis is a chronic bone infection characterized by progressive osteonecrosis and dead bone formation, which is closely related to persistent infection and chronic inflammation. Exosomes derived from bone marrow-derived mesenchymal stem cells (BMSC) play an important role in bone tissue regeneration and the modulation of inflammatory processes. However, their role and mechanism of action in osteomyelitis have not been reported so far.
View Article and Find Full Text PDFNephrology (Carlton)
November 2024
Department of Nephrology, Taiyuan Hospital of Peking University First Hospital, Taiyuan, Shanxi, China.
Background: As an initial treatment for primary membranous nephropathy (PMN), there remains a significant proportion of patients for whom rituximab is not fully effective. Here, we aimed to assess the effectiveness and safety of obinutuzumab as initial treatment in patients with PMN.
Methods: In this observational case series, patients diagnosed with PMN and treated with obinutuzumab as initial treatment were included.